Sumitomo Mitsui Trust Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-35,519
| Closed | -$8.65M | – | 1043 |
|
|
2025
Q1 | $8.65M | Sell |
35,519
-876
| -2% | -$213K | 0.01% | 701 |
|
|
2024
Q4 | $12M | Sell |
36,395
-1,569
| -4% | -$515K | 0.01% | 694 |
|
|
2024
Q3 | $12.7M | Sell |
37,964
-8,426
| -18% | -$2.82M | 0.01% | 689 |
|
|
2024
Q2 | $12.7M | Sell |
46,390
-4,170
| -8% | -$1.14M | 0.01% | 688 |
|
|
2024
Q1 | $17.5M | Sell |
50,560
-1,004
| -2% | -$347K | 0.01% | 726 |
|
|
2023
Q4 | $16.6M | Sell |
51,564
-2,108
| -4% | -$681K | 0.01% | 726 |
|
|
2023
Q3 | $19.2M | Sell |
53,672
-735
| -1% | -$263K | 0.02% | 706 |
|
|
2023
Q2 | $20.6M | Sell |
54,407
-7,551
| -12% | -$2.86M | 0.02% | 703 |
|
|
2023
Q1 | $29.7M | Sell |
61,958
-850
| -1% | -$407K | 0.02% | 631 |
|
|
2022
Q4 | $26.4M | Sell |
62,808
-2,695
| -4% | -$1.13M | 0.02% | 657 |
|
|
2022
Q3 | $27.3M | Buy |
65,503
+146
| +0.2% | +$60.9K | 0.02% | 648 |
|
|
2022
Q2 | $32.4M | Sell |
65,357
-1,974
| -3% | -$977K | 0.02% | 629 |
|
|
2022
Q1 | $37.9M | Buy |
67,331
+452
| +0.7% | +$255K | 0.03% | 611 |
|
|
2021
Q4 | $50.5M | Sell |
66,879
-50,181
| -43% | -$37.9M | 0.03% | 532 |
|
|
2021
Q3 | $87.3M | Sell |
117,060
-17,998
| -13% | -$13.4M | 0.05% | 378 |
|
|
2021
Q2 | $87M | Buy |
135,058
+1,823
| +1% | +$1.17M | 0.05% | 386 |
|
|
2021
Q1 | $76.1M | Buy |
133,235
+33,241
| +33% | +$19M | 0.05% | 413 |
|
|
2020
Q4 | $58.3M | Buy |
99,994
+16,568
| +20% | +$9.66M | 0.04% | 476 |
|
|
2020
Q3 | $43M | Sell |
83,426
-5,579
| -6% | -$2.88M | 0.03% | 530 |
|
|
2020
Q2 | $40.2M | Buy |
89,005
+805
| +0.9% | +$363K | 0.03% | 551 |
|
|
2020
Q1 | $30.9M | Buy |
88,200
+11,633
| +15% | +$4.08M | 0.03% | 558 |
|
|
2019
Q4 | $28.3M | Buy |
+76,567
| New | +$28.3M | 0.02% | 621 |
|